Key Financial Data Of Group

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7714364

Concept 2018-04-01 to
2018-12-31
As at
2018-12-31
2018-10-01 to
2018-12-31
2017-04-01 to
2018-03-31
As at
2018-03-31
2017-04-01 to
2017-12-31
As at
2017-12-31
2017-10-01 to
2017-12-31
Key financial data of group
Business results of group
Net sales
72,584,000,000 JPY
98,430,000,000 JPY
76,891,000,000 JPY
Ordinary profit (loss)
20,254,000,000 JPY
27,854,000,000 JPY
24,062,000,000 JPY
Profit (loss) attributable to owners of parent
14,247,000,000 JPY
19,043,000,000 JPY
16,859,000,000 JPY
Comprehensive income
13,901,000,000 JPY
20,753,000,000 JPY
18,481,000,000 JPY
Net assets
118,252,000,000 JPY
113,874,000,000 JPY
111,604,000,000 JPY
Total assets
151,483,000,000 JPY
152,417,000,000 JPY
149,810,000,000 JPY
Basic earnings (loss) per share
356.84
136.13
470.54
416.06
148.57
Diluted earnings per share
Equity-to-asset ratio
0.781 xbrli:pure
0.747 xbrli:pure
0.745 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.